Epidemiology of non fatal major adverse cardiovascular events in children with diabetes

被引：0
|
作者：
Ali, Ayad K. [1 ]
Lakshmanan, Mark C. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
175
引用
收藏
页码：88 / 89
页数：2
相关论文
共 50 条
  • [1] PREDICTORS OF STATIN UTILIZATION IN US PATIENTS WITH NON-FATAL MAJOR ADVERSE CARDIOVASCULAR EVENTS
    Williams, A. O.
    Fan, W.
    Armstrong, S.
    Demissie, K.
    VALUE IN HEALTH, 2017, 20 (05) : A264 - A264
  • [2] A paradigm shift for cardiovascular outcome evaluation in diabetes: Major adverse cardiovascular events (MACE) to major adverse vascular events (MAVE)
    Rastogi, Ashu
    Sudhayakumar, Anand
    Schaper, Nicolaas C.
    Jude, Edward B.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (11)
  • [3] SYSTEMATIC LITERATURE REVIEW OF UTILITY DECREMENTS ASSOCIATED WITH THE NON-FATAL MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE)
    Jindal, R.
    Natani, H.
    Gogna, S.
    Yenamandra, J.
    Laires, P. A.
    Cristino, J.
    VALUE IN HEALTH, 2018, 21 : S116 - S116
  • [4] Non-dipping heart rate & major adverse cardiovascular events in type 2 diabetes mellitus
    Vassallo, L.
    Xuereb, R. G.
    Fava, S.
    Magri, C.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2408 - 2408
  • [5] Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetes
    Abegaz, Tadesse M.
    Baljoon, Ahmead
    Kilanko, Oluwaseun
    Sherbeny, Fatimah
    Ali, Askal Ayalew
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 164
  • [6] Prediabetes and the Incidence of Major Adverse Cardiovascular Events
    Booth, Gillian L.
    Rezai, Mohammad R.
    Atzema, Clare
    Austin, Peter C.
    Bhatia, Sacha
    Bierman, Arlene S.
    Clemens, Kristin K.
    Johnston, Sharon
    Ko, Dennis T.
    Lee, Douglas S.
    Tu, Karen
    Tu, Jack V.
    DIABETES, 2017, 66 : A81 - A82
  • [7] Chronic Kidney Disease Predicts Adverse Major Cardiovascular Events and Adverse Limb Events in Patients With Diabetes and Peripheral Arterial Disease
    Rerkasem, Amaraporn
    Mangklabruks, Ampica
    Buranapin, Supawan
    Sony, Kiran
    Inpankaew, Nimit
    Rerkasem, Rath
    Pongtam, Sasinat
    Phirom, Kochaphan
    Rerkasem, Kitttipan
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2024, 23 (01): : 19 - 26
  • [8] Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with type 2 diabetes
    Mittermayer, Friedrich
    Krzyzanowska, Katarzyna
    Wolzt, Michael
    Schernthaner, Guntram
    DIABETES, 2007, 56 : A175 - A175
  • [9] RECURRENT DIABETIC KETOACISOSIS PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS IN TYPE 1 DIABETES
    Fallahi, I.
    Qeadan, F.
    Burge, M. R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (01) : 172 - 172
  • [10] Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study
    Hojlund, Mikkel
    Wagner, Christina Blanner
    Wesselhoeft, Rikke
    Andersen, Kjeld
    Fink-Jensen, Anders
    Hallas, Jesper
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 (04) : 501 - 512
12345